Literature DB >> 3910556

Graft-versus-host reactions and disease.

G W Santos, A D Hess, G B Vogelsang.   

Abstract

Mesh:

Substances:

Year:  1985        PMID: 3910556     DOI: 10.1111/j.1600-065x.1985.tb01158.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  14 in total

1.  Allogeneic and autologous bone-marrow transplantation.

Authors:  H J Deeg
Journal:  Can Fam Physician       Date:  1988-11       Impact factor: 3.275

2.  Complete sequential regeneration of graft-vs.-host-induced severely dysplastic thymuses. Implications for the pathogenesis of chronic graft-vs.-host disease.

Authors:  T Ghayur; T A Seemayer; A Xenocostas; W S Lapp
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

3.  White pulp reconstitution after human bone marrow transplantation.

Authors:  A Nakayama; N Hirabayashi; M Ito; K Kasai; M Fujino; M Ohbayashi; J Asai
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

4.  Allogeneic transplantation using CD34+ selected peripheral blood progenitor cells combined with non-mobilized donor T cells for refractory severe aplastic anaemia.

Authors:  Enkhtsetseg Purev; Xin Tian; Georg Aue; Jeremy Pantin; Phuong Vo; Reem Shalabi; Robert N Reger; Lisa Cook; Catalina Ramos; Elena Cho; Tat'yana Worthy; Hanh Khuu; David Stroncek; Neal S Young; Richard W Childs
Journal:  Br J Haematol       Date:  2017-02-07       Impact factor: 6.998

5.  Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells.

Authors:  J W Young; R M Steinman
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

6.  Scleroderma renal crisis as a possible complication of cyclosporin A withdrawal.

Authors:  P Casoli; C Carretti; B Tumiati
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

7.  Blood and Marrow Transplant Clinical Trials Network: progress since the State of the Science Symposium 2007.

Authors:  James L M Ferrara
Journal:  Biol Blood Marrow Transplant       Date:  2013-11-12       Impact factor: 5.742

8.  Effect of selective decontamination of the digestive tract of donor and recipient on the occurrence of murine delayed-type graft-versus-host disease.

Authors:  D Veenendaal; F de Boer; D Van der Waaij
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

9.  Antigen and lymphopenia-driven donor T cells are differentially diminished by post-transplantation administration of cyclophosphamide after hematopoietic cell transplantation.

Authors:  Duncan Ross; Monica Jones; Krishna Komanduri; Robert B Levy
Journal:  Biol Blood Marrow Transplant       Date:  2013-06-29       Impact factor: 5.742

Review 10.  High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation.

Authors:  Leo Luznik; Ephraim J Fuchs
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.